C37 diagnosis code · Billable category · FY2027
C37 Malignant neoplasm of thymus
- Billable
- CC
- HCC 21
- POA reported
C37 ICD-10 code: a billable diagnosis code in FY2027; the category has no subdivisions.
Where it sits
- Chapter 2 Neoplasms (C00-D49)
- C30-C39 Malignant neoplasms of respiratory and intrathoracic organs (C30-C39)
- C37 Malignant neoplasm of thymus
- CC / MCC
- CC
- MS-DRG
- 826-828, 829-830, 843-845
- HCC V28
- 21
- POA
- Reported
- Code Editor
- –
- Index entries
- 9
Instructions
At C37
Excludes1
- malignant carcinoid tumor of the thymus (C7A.091) C7A.091
Notes that also apply
Block C30-C39 instructions (Includes 1, Excludes1 1): printed on the block page.
Chapter 2 instructions (Notes 8): printed on the chapter 2 page.
Index entries
NCHS Alphabetic Index. Index first, then the Tabular List.
Medicare grouping and edits
| CC / MCC | CC |
|---|---|
| PDX exclusion list | 0297 (2 codes) |
| Appendix B | MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms, MS-DRG 826-828 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC…); MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms, MS-DRG 829-830 (Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC…); MDC 17 Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms, MS-DRG 843-845 (Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC…) |
| Code Editor | – |
| POA | Reported |
| HCC V28 | HCC 21 Lymphoma and Other Cancers |
CC as a secondary diagnosis, not when the principal diagnosis is on its PDX exclusion list.
CMS: MS-DRG v44 (Appendix B, C), MCE v44, POA list FY2027, 2027 Initial ICD-10-CM Mappings. What the rows mean.